|
Sunlight
Products
Sunlight devices, with radiation-free, user-friendly technologies to
provide services that fit physicians' needs, are marketed both to
small practices and to hospitals. The products are very reliable,
highly accurate, moderately priced, and offer a profitable business
model.
Sunlight's osteoporosis management products include Sunlight OmnisenseŽ
7000S, a noninvasive quantitative-ultrasound device developed
for quick, user-friendly assessment of fracture risk and
osteoporosis management, and Sunlight OmnisenseŽ
8000S, the world's only multi-site portable bone assessment
device.
Products for the pediatric market include Sunlight BonAge, a
quantitative ultrasound device for accurate bone age evaluation to
be released in 2003. Current pediatric products are Sunlight OmnisenseŽ
7000P for monitoring bone development in children and
adolescents and Sunlight PREMIER for bone
assessment in premature babies.
Accuracy
Comparison
studies between Omnisense and DXA of fractured and non-fractured
subjects, demonstrate Omnisense's enhanced capability to correctly
classify osteoporotic patients (high sensitivity).
Hip Fracture
Prediction
A number of clinical
studies substantiate that Omnisense measurements at the Distal 1/3
Radius and phalanx reliably predict hip fractures.
Monitoring Bone
Changes
Omnisense monitors bone
changes due to bone related disorders and in response to
treatment.
WHO Compliant
Omnisense
results are compatible with World Health Organization criteria for
osteoporosis diagnosis. Results are automatically compared to a
selectable built-in reference database and are expressed as T-Scores
and Z-Scores.
|
